| A Network Meta-Analysis of Vaccination Schedules and the Effect on Humoral and Intestinal Immunity Against Poliovirus G Macklin, NC Grassly, RW Sutter, O Mach, AS Bandyopadhyay, ... Kathleen M, A Network Meta-Analysis of Vaccination Schedules and the Effect …, 2018 | | 2018 |
| A Network Meta-analysis of Vaccine Schedules and the Effect on Humoral and Intestinal Immunity Against Poliovirus GR Macklin, NC Grassly, RW Sutter, O Mach, AS Bandyopadhyay, ... Epidemiology and vaccination strategies against type-2 vaccine-derived …, 2022 | | 2022 |
| A New Live-Attenuated Poliovirus Vaccine Constructed by Rational Design Improves Safety by Preventing Reversion to Virulence MT Yeh, E Bujaki, M Smith, AJ Weiner, A Bandyopadhyay, P Van Damme, ... Available at SSRN 3400856, 2019 | 1 | 2019 |
| A novel tool to eradicate an ancient scourge: the novel oral polio vaccine type 2 story AS Bandyopadhyay, S Zipursky The Lancet Infectious Diseases 23 (2), e67-e71, 2023 | 30 | 2023 |
| A randomized phase 4 study of immunogenicity and safety after monovalent oral type 2 Sabin poliovirus vaccine challenge in children vaccinated with inactivated poliovirus … AS Bandyopadhyay, C Gast, EB Brickley, R Rüttimann, R Clemens, ... The Journal of infectious diseases 223 (1), 119-127, 2021 | 9 | 2021 |
| A randomized phase 4 study of immunogenicity and safety following monovalent oral type 2 Sabin polio vaccine challenge in IPV-vaccinated children in Lithuania AS Bandyopadhyay, C Gast, EB Brickley, R Ruttimann, R Clemens, ... J Infect Dis 10, 2020 | 8 | 2020 |
| A review of the most commonly used methods for sample collection in environmental surveillance of poliovirus G Matrajt, B Naughton, AS Bandyopadhyay, JS Meschke Clinical Infectious Diseases 67 (suppl_1), S90-S97, 2018 | 46 | 2018 |
| Assessing and Mitigating Local Vulnerabilities to Completeness of Global Polio Eradication AS Bandyopadhyay, WA Orenstein Journal of the Pediatric Infectious Diseases Society 11 (1), 3-4, 2022 | | 2022 |
| Assessment of genetic changes and neurovirulence of shed Sabin and novel type 2 oral polio vaccine viruses R Wahid, L Mercer, A Macadam, S Carlyle, L Stephens, J Martin, ... NPJ vaccines 6 (1), 94, 2021 | 14 | 2021 |
| Characterizing environmental surveillance sites in Nigeria and their sensitivity to detect poliovirus and other enteroviruses AW Hamisu, IM Blake, G Sume, F Braka, A Jimoh, H Dahiru, M Bonos, ... The Journal of infectious diseases 225 (8), 1377-1386, 2022 | 25 | 2022 |
| Chilean IPV/bOPV study group Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised … M O’Ryan, AS Bandyopadhyay, R Villena, M Espinoza, J Novoa, ... Lancet Infect Dis 15 (11), 1273-82, 2015 | 9 | 2015 |
| City, Panama 4. Sistema Nacional de Investigación, Senacyt, Panama 5. Cevaxin, Panama City, Panama 6. VaxTrials, Panama City, Panama 7. Fighting Infectious Diseases in Emerging … C Gast, AS Bandyopadhyay, X Sáez-Llorens, T De Leon, R DeAntonio, ... | | 2021 |
| Community structure mediates Sabin 2 polio vaccine virus transmission M Famulare, W Wong, R Haque, JA Platts-Mills, P Saha, AB Aziz, ... medRxiv, 2020.07. 01.20144501, 2020 | 3 | 2020 |
| Community transmission of type 2 poliovirus after cessation of trivalent oral polio vaccine in Bangladesh: an open-label cluster-randomised trial and modelling study M Taniuchi, M Famulare, K Zaman, MJ Uddin, AM Upfill-Brown, T Ahmed, ... The Lancet Infectious Diseases 17 (10), 1069-1079, 2017 | 33 | 2017 |
| Comparing clinical characteristics between hospitalized adults with laboratory-confirmed influenza A and B virus infection S Su, SS Chaves, A Perez, T D'Mello, PD Kirley, K Yousey-Hindes, ... Clinical Infectious Diseases 59 (2), 252-255, 2014 | 145 | 2014 |
| Correction to Lancet Infect Dis 2023; published online Nov 24. https://doi. org/10.1016/S1473-3099 (23) 00505-4 AS Bandyopadhyay, R Lopez Cavestany, IM Blake | | 2023 |
| Economics of Eradication: Counting on the Polio Experience AS Bandyopadhyay, WA Orenstein The Journal of Infectious Diseases 226 (8), 1301-1303, 2022 | 1 | 2022 |
| Effectiveness of poliovirus vaccines against circulating vaccine-derived type 2 poliomyelitis in Nigeria between 2017 and 2022: a case-control study LV Cooper, TB Erbeto, AA Danzomo, HW Abdullahi, K Boateng, ... The Lancet Infectious Diseases, 2024 | 8 | 2024 |
| Emergence of vaccine-derived poliovirus in high-income settings in the absence of oral polio vaccine use M Hill, AS Bandyopadhyay, AJ Pollard The Lancet 400 (10354), 713-715, 2022 | 34 | 2022 |
| Emerging global epidemiology of measles and public health response to confirmed case in Rhode Island AS Bandyopadhyay, U Bandy rhode Island medIcal journal 96 (2), 41, 2013 | 9 | 2013 |
